<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-038944</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Central serous chorioretinopathy as a complication of epitheliopathy under treatment with glucocorticoids</dc:title>
<dc:description xml:lang="en">Case report: We present cases of two patients who were examined in our department with the diagnosis of epitheliopathy following treatment with oral and topical glucocorticoids. They were referred because of loss of visual acuity. The ophthalmic examination established the diagnosis of central serous chorioretinopathy and it was decided to stop treatment with glucocorticoids.Discussion: The pathogenesis of the central serous chorioretinopathy is still imprecisely known, but it has been related to several situations characterized by exposure to high levels of endogenous or exogenous glucocorticoids. Both of these cases provide more evidence of the potential association between corticosteroids and the acute manifestations of central serous chorioretinopathy</dc:description>
<dc:creator>Fernández Hortelano, A</dc:creator>
<dc:creator>Heras Mulero, H</dc:creator>
<dc:creator>García Layana, A</dc:creator>
<dc:creator>Sádaba, L. M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Se presentan 2 pacientes que acuden a la consulta con el diagnóstico de epitelitis multifocal en tratamiento con corticoides vía oral y vía tópica. Como sintomatología refieren disminución de agudeza visual. A la exploración se diagnostica una coriorretinopatía serosa central y se suspende el tratamiento con corticoides.Discusión: La etiopatogenia de la coriorretinopatía serosa central permanece aún desconocida aunque se ha relacionado con diversas situaciones caracterizadas por la exposición a niveles elevados de glucocorticoides (CTC) endógenos o exógenos. Los dos casos que presentamos constituyen una evidencia más de que el tratamiento con corticoides puede precipitar o agravar esta patología</dc:description>
<dc:source>Arch Soc Esp Oftalmol;80(4): 255-258, abr. 2005. ilus</dc:source>
<dc:identifier>ibc-038944</dc:identifier>
<dc:title xml:lang="es">Coroidopatía serosa central como complicación de epitelitis en tratamiento con corticoides</dc:title>
<dc:subject>^d24564^s22016</dc:subject>
<dc:subject>^d24564^s22067</dc:subject>
<dc:subject>^d24564^s22036</dc:subject>
<dc:subject>^d12581^s22016</dc:subject>
<dc:subject>^d12581^s22036</dc:subject>
<dc:subject>^d23247</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6082^s22020</dc:subject>
<dc:subject>^d12581^s22067</dc:subject>
<dc:subject>^d38335</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200504</dc:date>
</metadata>
</record>
</ibecs-document>
